The United States

George Clinical in The United States

George Clinical, leading Asia-Pacific CRO, expands into US with acquisition of a specialised oncology CRO Division

Headquartered in Sydney, Australia, George Clinical has offices in China, India, Hong Kong, South Korea, Taiwan, Malaysia, New Zealand, United Kingdom, Czech Republic and now the USA.

Over the years, George Clinical has grown rapidly across the Asia-Pacific region and is continuing to develop global operations. The combination of a strong commercial proficiency and clinical research and scientific excellence positions George Clinical as a high quality, global CRO with substantial clinical and scientific assets.

George Clinical now has substantial operations in the USA, with 42 staff and leaders in oncology trials both operationally and scientifically. We are here to support our US customers with their CRO needs and to lead oncology trials across our core operational facilities in the Asia Pacific region.

George Clinical US News

George Clinical, leading Asia-Pacific CRO, expands into US with acquisition of a specialised oncology CRO Division

George Clinical, a leading full-service CRO in the Asia-Pacific region and Vector Oncology, a Memphis-based leader in oncology research and data analytics, formally announced today that George Clinical has acquired Vector Oncology’s Pharma Services (CRO) Division…

High blood pressure linked to common heart valve disorder

For the first time, a strong link has been established between high blood pressure and the most common heart valve disorder in high-income countries, by new research from The George Institute for Global Health at the University of Oxford.

Omega-6 fats may help prevent type 2 diabetes

The risk of developing type 2 diabetes could be significantly reduced by eating a diet rich in omega-6 polyunsaturated fats, a new study suggests.

Latest NHMRC grants a boost in the fight against chronic disease and injury

Australia's National Health and Medical Research Council (NHMRC) has awarded a total of $4.2 million in grants to The George Institute for Global Health to fund projects addressing some of the world's biggest health concerns.

Action on Salt China launched in Beijing

On 11th October, 2017, the Launch event of ASC Programme – NIHR Global Health Research Unit Action on Salt China – was successfully held in Beijing.

Women with heart disease less likely to reach treatment targets than men

Women with coronary heart disease are less likely to achieve treatment targets than men, finds a study published by the journal Heart today.

#EatLessSalt - a salt literacy campaign in Chandigarh, India

The George Institute for Global Health, India, in collaboration with the Chandigarh Commission for Protection of Child Rights and the School of Public Health, PGIMER, has launched #EatLessSalt, a “Salt Literacy Campaign” in schools of the city of Chandigarh. The campaign aim...

Details